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Nearly full-length genome sequencing of HIV-1 using peripheral blood mononuclear cells (PBMC) DNA as a template for PCR is
now a relatively routine laboratory procedure. However, this has not been the case when using virion RNA as the template and
this has made full genome analysis of circulating viruses difficult. Therefore, a well-developed procedure for sequencing of full-
length HIV-1 RNA directly from plasma was needed. Plasma from U.S. donors representing a range of viral loads (VL) was used
to develop the assay. RNA was extracted from plasma and reverse-transcribed. Two or three overlapping regions were PCR
amplified to cover the entire viral genome and sequenced for verification. The success of the procedure was sensitive to VL but
was routinely successful for VL greater than 10
5 and the rate declined in proportion to the VL. While the two-amplicon strategy
had an advantage of increasing the possibility of amplifying a single species of HIV-1, the three-amplicon strategy was more
successful in amplifying samples with low viral loads. This protocol provides a useful tool for molecular analysis to understand
the HIV epidemic and pathogenesis, as well as diagnosis, therapy and future vaccine strategies.
Citation: Nadai Y, Eyzaguirre LM, Constantine NT, Sill AM, Cleghorn F, et al (2008) Protocol for Nearly Full-Length Sequencing of HIV-1 RNA from
Plasma. PLoS ONE 3(1): e1420. doi:10.1371/journal.pone.0001420
INTRODUCTION
Since the first complete sequence of the HIV-1 genome was
published in 1985 [1], there have been numerous reports
documenting the genetic variability of the virus based on
sequencing. In the HIV sequence database [2] there are currently
1404 HIV-1 sequences greater than 8 kb in length. However, the
vast majority of these sequences have been generated using DNA
from either peripheral blood mononuclear cells (PBMC) or
cultured cells [1,3–5]. In fact, only 74 sequences from 47
individuals are identified as derived from RNA and all of them
were generated using cloning; there are no full-length HIV-1
sequences that are clearly from direct PCR amplification and
sequencing of virion RNA. The reason for this is that generating a
single, nearly full-length PCR amplicon of HIV-1 using virion
RNA as the template has been relatively difficult.
The ability to monitor the sequence of the full genome of HIV-1
in the virion is important for many reasons. Virion RNA reflects
currently replicating virus, and thus has more pathogenic
significance than the proviral DNA present in PBMC [6–9].
Proviral DNA contains high levels of integrated defective viral
sequences [6]. Thus the analysis of virion RNA is ideal for
studying the pathogenesis and epidemiology of HIV-1. Moreover,
it is often the case that PBMC are not available from important
study populations, and studies must be conducted using plasma or
serum. Such studies have often been restricted to partial genome
characterization because of the technical difficulty of using RNA
as the template [10,11].
A well-developed strategy for amplification and sequencing of
nearly full-length HIV-1 directly from plasma viral RNA was
needed. Standard sequencing methods require efficient PCR
amplification and this is more difficult in viral RNA samples
because of common problems in synthesizing full-length cDNA.
Recent improvements in commercially available RNase H
2 free
reverse transcriptase (RT) have made it possible to synthesize
cDNA for nearly full-length HIV-1 RNA genomes (,9 kb). In this
report, optimal conditions for reverse transcription and PCR
amplification (RT-PCR) of HIV-1 RNA in plasma samples were
defined, resulting in a simple, sensitive, and effective assay to
sequence nearly full-length HIV-1 genomes from virion RNA.
MATERIALS AND METHODS
Study Subjects
Plasma samples were obtained from the Molecular Diagnostics
Laboratory at the University of Maryland Medical Center in
Baltimore, MD, a CAP-accredited facility. Unidentified, archived
samples were selected based on the VL, ranging from 1,000 to
over 75,0000 copies/ml. VL testing was performed using the
COBAS Amplicor HIV-1 Monitor Test, version 1.5. (Roche
Molecular Systems Inc., Durham, NC).
RNA Extraction
RNAwasextractedfrom500 mlHIV-1positiveplasmaspecimensusing
QIAamp Viral RNA Mini Assay (Qiagen, Valencia, CA). Virions were
initially concentrated from the plasma or serum by centrifugation at
21,0006g for 75 min. All but 140 ml of the supernatant was removed
before lysis buffer was added. Extracted RNA (60 ml) was either
immediately reverse transcribed or stored at 280uCu n t i lu s e .
Reverse Transcription
The methods for RT- PCR are illustrated in Figure 1. Reverse
transcription of the RNA was performed by priming with
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VPUoutR1 (Table 1) in the vpu gene. The extracted RNA (3 ml) was
reverse transcribed in a total volume of 20 ml with 500 mM dNTP,
2.5 mM primer, 16RT buffer, 5 mM MgCl2, 10 mM DTT, 40 U
RnaseOUT, and 400 U SuperScript
TM III RNase H
2 RT
(Invitrogen, Carlsbad, CA). The RNA, primer and dNTPs were
first incubated at 65uC for 5 minutes, then the remaining reagents
were added for cDNA synthesis at 50uC for 2 hours, followed by
85uC for 5 minutes. Then 2 U E. coli RNase H (Invitrogen,
Carlsbad, CA) was added, and the reaction tubes were incubated at
37uC for 20 minutes followed by 70uC for 15 minutes.
PCR Amplification
Two or three regions of the viral genome were independently
amplified using nested PCR from the cDNA to contain a nearly
full-length genome of HIV-1 (amplification primers listed in
Figure 1 and Table 1). The two-amplicon strategy consisted of one
amplicon of about 2.6-kb consisting of gag and part of pol (nts 769–
3338 HXB-2 (Genbank Acc No: K03455)) and another amplicon
of approximately 7.0-kb stretching from the 59 end of pol to the
middle of nef (nts 2143–9181 HXB-2). The reaction volume was
50 ml, containing 16 PCR buffer, 350 mM dNTP mixture,
0.4 mM of each primer and 5 U Expand Long Template PCR
enzyme mixture (Roche Diagnostics, Indianapolis, IN). Cycling
conditions were 94uC for 2 minutes and then 10 cycles of (94uC
10 s, 60uC3 0s ,6 8 uC 3 min), then 20 cycles of (94uC1 0s ,5 5 uC
30 s, 68uC 3 min) followed by 68uC for 10 minutes. For the
second amplicon, cycling conditions were the same, except that
the annealing temperature for first 10 cycles was 65uC and the
incubation at 68uC in each cycle was for 8 minutes. A hot-start
using DynaWax (Finnzymes, Espoo, Finland) was employed in
each PCR, with two layers separated by wax. In the bottom layer
were the dNTPs and primers while the top layer contained the
PCR buffer, DNA polymerase and template cDNA. Limiting
dilution of template into the first round was used to minimize the
chances of producing mosaic molecules. The amplicon that could
be obtained with the lowest amount of cDNA input was applied to
the following sequencing step.
A three-amplicon strategy was used as needed. The first
amplicon was the gag-pol amplicon described above, the second
spanned pol to vpu (nts 2483–6231 HXB-2) and the third env to nef
(nts 5861–9181 HXB-2) (Figure 1 and Table 1). The cycling
Figure 1. Nearly full-length RT-PCR method. Viral RNA was reverse-transcribed by priming with UNINEF 79 or with VIF-VPUoutR1 using SuperScript
TM
III RNase H
2 RT. The locations of all the primers used for cDNA synthesis and nested PCR were depicted in this diagram with the map of the complete
HIV-1 genome. Two different strategies were employed to amplify the nearly full-length genome: one amplified the 2.6-kb (gag-pol) and 7.0-kb (pol-
nef) fragments with the overlap of 797-bp, and the other amplified three overlapping fragments of 2.6-kb (gag-pol), 3.7-kb (pol-vpu) and 3.3-kb (env-
nef) with the 797-bp and 321-bp over lap regions, respectively.
doi:10.1371/journal.pone.0001420.g001
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region, except that the incubation at 68uC in each cycle was for
4 minutes rather than 3 minutes.
Sequencing
ThePCRproductsforsequencing were filteredwith MicroconYM-
50 (Millipore Corporation, Bedford, MA, USA), and then the PCR
products were directly sequenced using fluorescently labeled
dideoxy chain terminators (BigDyeH Terminator v3.1 Cycle
Sequencing Assay, Applied Biosystems) and an automated 3130xl
sequencer (Applied Biosystems). The primary set of sequencing
primers used for each amplicon is listed in a supplemental material
(Table S1). Sequencing reactions were repeated with alternate
primers as needed to fill any gaps present to complete the
sequencing of both DNA strands in each amplicon. The nearly
full-length genome sequence was assembled by overlapping the
sequences of the two or three amplicons and merging them into one
sequence as long as the two were greater than 98% homologous.
RESULTS
Optimization of Extraction Method
QIAamp viral RNA mini assay was selected after comparisons
with other commercially available extraction assays for its
reliability and efficacy. RNA extraction using a volume of
500 ml was useful to improve sensitivity for low VL samples. To
show the standardized correlation between VLs and RT-PCR
efficacies, all the samples listed in Table 2 were concentrated from
the original volume of 500 ml.
Optimization of Reverse Transcription
Several different types of commercially available RT were
compared, and SuperScript
TM III RNase H
2 RT had the highest
yield. The incubation temperature for cDNA synthesis was 50uC,
which was recommended by the manufacturer. The yield did not
increase when temperature was raised to 53uC and 55uC.
The following three primers were compared for the reverse
transcription: Oligo dT, random hexamer and the specific primer
for HIV-1 genome, UNINEF 79. Generally, priming with Oligo
dT and UNINEF 79 resulted in much better yields for synthesizing
full-length cDNA than random hexamer, and UNINEF 79 tended
to have more consistent results than Oligo dT. Therefore,
UNINEF 79 was used for all the reverse transcription reactions
to obtain the data for the further experiments.
Originally 200 U of SuperScript
TM III RT was employed in a
21 mL reaction volume; however, the increased input of the
enzyme to 400 U significantly improved the efficacy of RT-PCR.
In the samples with the VL range of 10,000–200,000 copies/ml,
Table 1. Primers for the amplification of nearly full-length HIV-1 genome.
..................................................................................................................................................
Primer
a Position
b Sequence (59R39) Length Tm (uC)
msf12b (+) 623–649 AAATCTCTAGCAGTGGCGCCCGAACAG 27 76.04
f2nst (+) 769–793 GCGGAGGCTAGAAGGAGAGAGATGG 25 71.73
pro5F (+) 1996–2018 AGAAATTGCAGGGCCCCTAGGAA 23 71.04
pro3F (+) 2143–2166 AGANCAGAGCCAACAGCCCCACCA 24 75.44
POLoutF1 (+) 2253–2277 CCTCAAATCACTCTTTGGCARCGAC 25 70.36
POLinF1 (+) 2483–2509 AGGACCTACRCCTGTCAACATAATTGG 27 66.76
proRT (2) 3308–3338 TTTCCCCACTAACTTCTGTATGTCATTGACA 31 70.77
RT3474R (2) 3453–3477 GAATCTCTCTGTTTTCTGCCAGTTC 25 65.18
ENVoutF1 (+) 5550–5574 AGARGAYAGATGGAACAAGCCCCAG 25 68.83
ENVinF1 (+) 5861–5884 TGGAAGCATCCRGGAAGTCAGCCT 24 72.73
VIF-VPUinR1 (2) 6207–6231 CTCTCATTGCCACTGTCTTCTGCTC 25 69.28
VIF-VPUoutR1 (2) 6324–6352 GGTACCCCATAATAGACTGTRACCCACAA 29 68.49
nefyn05 (2) 9157–9181 GTGTGTAGTTCTGCCAATCAGGGAA 25 68.9
UNINEF 79 (2) 9605–9632 GCACTCAAGGCAAGCTTTATTGAGGCTT 28 72.59
a(+) Sense primer, (2) Antisense primer.
bPositions according to HXB2 Numbering System.
doi:10.1371/journal.pone.0001420.t001
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Table 2. Comparative Sensitivities of HIV-1 Viral loads in Plasma samples for RT-PCR Detection of HIV-1 RNA.
..................................................................................................................................................
Viral Load (HIV-1 RNA copies/ml)
.750,000 100,000–200,000 10,000–100,000 2,000–10,000 1,000–2,000
(% Efficiency
a) (% Efficiency
a) (% Efficiency
a) (% Efficiency
a) (% Efficiency
a)
PCR Regions n=8 n=8 n=5 n=4 n=2
Env-Nef,3.3 kb 8/8 (100%) 8/8 (100%) 4/5 (80%) 3/4 (75%) 0/2 (0%)
Pol-Vpu,3.7 kb 8/8 (100%) 6/8 (75%) 2/5 (40%) 0/4 (0%) 0/2 (0%)
Gag-Pol,2.6 kb 8/8 (100%) 6/8 (75%) 2/5 (40%) 1/4 (25%) 0/2 (0%)
Pol-Nef,7.0 kb 6/8 (75%) 4/8 (50%) 2/5 (40%) 0/4 (0%) 0/2 (0%)
aPositive polymerase chain reaction product.
doi:10.1371/journal.pone.0001420.t002
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PLoS ONE | www.plosone.org 3 January 2008 | Issue 1 | e1420an increase of 30% was observed for the 7.3 kb pol-nef region and
10% for the 2.6 kb gag-pol region.
Primer design and optimization of PCR
The primers, listed in the legend to Table 1, were designed using
the full-length genome alignment of diverse group M HIV-1
strains from the HIV sequence database [2]. The conserved sites
surrounding or within the target region of the HIV-1 sequences
were examined for optimal PCR primer sequences. The primers
were designed to achieve annealing at a temperature of .55uC,
and to avoid hairpins, self-priming, and primer-dimer formation.
Primers were screened for specificity and evaluated to be able to
amplify most of the strains within the diverse 9 subtypes of the
group M HIV-1 using the Primalign HIV sequence database tool
[12]. In addition, ambiguous bases within the primers were used to
represent the genetic diversity present at the primer binding sites.
Comparative Sensitivities of HIV-1 VLs for successful
PCR amplification
The ability to successfully amplify and sequence HIV-1 RNA from
plasma was dependent on VL. The frequency of positive
amplifications of the four different fragments obtained in the 27
samples is shown in Table 2. The efficacy on the table is based on
cDNA synthesis from the 39end of viral RNA with primer,
UNINEF 79. In our initial strategy of amplifying two regions, a low
efficiency of amplification of the 7.0-kb pol-nef fragment was
observed in the samples with low VL. Therefore, the three-
amplicon strategy was implemented for the samples that failed
using the first approach. To measure the correlation between the
VL and the efficacy of amplification, the PCR reactions were
repeated at least 4 times with different dilutions to determine each
as either positive or negative. The success rates for obtaining all
amplicons for full-length were 100% in samples with a VL greater
than 750,000 copies/ml, 75% in samples with a VL of 100,000–
200,000 copies/ml, and 40% in samples with a VL of 10,000–
100,000 copies/ml. Finally, there was a 76% success rate if the
three-amplicon strategy were used for those with a VL of greater
than 10,000 copies/ml.
Reverse transcription was also performed priming with VIF-
VPUoutR1 for the samples with negative vif-vpu region amplifi-
cation results. Approximately 60% of the previously negative
samples were successfully amplified in the pol-nef and gag-pol region
after priming with VIF-VPUoutR1, resulting in 90% efficiency for
both regions for samples with a VL of greater than 10,000 copies/
ml (data not shown).
Analysis of Sequences of HIV-1 RNA
The reverse-transcription and PCR methods were verified by
directly sequencing the nested PCR products amplified in all three
regions in 15 samples. The amplified material present in strong
bands obtained with PCR was sufficient for good quality
sequences in direct automated fluorescent sequencing. All the
amplicons were sequenced separately and assembled for the nearly
full-length HIV-1 genome (sequence data will be published
separately). The resulting sequences were around 8500-bp
(nts 769–9181 HXB-2) and contained the nearly entire HIV-1
coding region, but lacked the 39end of the nef gene and U3 and R
of LTR regions (nts 9181–9636 HXB-2). All of the reading frames
were open without apparent insertion, deletion, or rearrangement.
In the 2-amplicon and 3-amplicon strategies, there were regions
of overlap between the adjacent amplicons. The overlapping
regions of 797-bp and 321-bp were carefully analyzed to assemble
the three fragments. Some overlapping regions displayed a small
number of heterogeneous single-base substitutions, but the most
common substitutions were G to A, which reflected the G to A
hypermutation of one of the templates but not the other. To
ensure that the sequence fragments were derived from the same
genomic species, two criteria had to be met to represent a
consensus sequence: the genetic distance had to be no greater than
2%, and the base differences had to be distributed evenly
throughout the overlapping region. If these two criteria were
met, a single sequence was generated; otherwise cDNA synthesis
and PCR amplification were repeated.
DISCUSSION
The accuracy of direct sequencing of full-length virion RNA from
HIV-1 relies on the ability to extract RNA from clinical materials,
to conduct cDNA synthesis, and to amplify the cDNA successfully.
The presence of an adequate number of intact RNA templates was
essential for accurate and complete reverse transcription. An
ultracentrifugation step to concentrate the viral particles before the
extraction of RNA contributed to increased success especially for
plasma samples with low VLs; a total of at least 250 virus copies
(10,000 copies/ml6500 ml plasma460 ml RNA63 ml used) had to
be present for the procedure to be successful. Therefore the low
abundance of viral RNA in some clinical samples remains a
barrier to this application. However, most HIV-1 infected
individuals have viral RNA titers that exceed 10,000 copies/ml
in plasma if untreated or if they are on nonsuppressive
antiretroviral therapy [13,14], and thus this protocol can be
employed for a broad range of plasma samples especially from
infected individuals not under treatment, on suboptimal therapy,
and in treatment failure.
Efficient cDNA synthesis is another important factor for
successful RT-PCR. Increased efficiency of cDNA synthesis has
been reported with a genetically engineered Moloney Murine
Leukemia Virus (M-MLV) RT devoid of RNase H activity
compared with unmodified M-MLV RT or AMV RT [15].
SuperScript
TM III RNase H
2 RT is M-MLV with such
introduced point mutations. The manufacturer (Invitrogen)
recommends 200 U of RT for sufficient cDNA synthesis; however
increasing the input of RT to 400 U significantly improved the
amplification results. It is probably because a significant amount of
thermal-sensitive RT is degraded during the incubation. Since the
original 200 U input is more cost-effective than 400 U, we
recommend the use of 200 U RT for samples with VL
.750,000 copies/ml.
To synthesize full-length cDNA efficiently has been difficult to
achieve presumably because the RT tends to be interrupted at
regions of secondary structure in mRNA templates [16,17],
resulting in the generation of truncated cDNA. Even though the
M-MLV RNase H
2 enzyme appears to be the best at negotiating
regions of secondary structure compared to other available in vitro
RT [18], as the length of mRNA increases, the RT is more likely
to encounter such regions, decreasing the chances of achieving the
59end of template RNA. At 55uC some secondary structural
elements begin to melt, and many existing protocols aim to
perform reactions at increased temperatures with minimum
interference with the activity of RT [19,20]. However, the half-
life of SuperScript
TM III RT significantly declines as temperature
is raised: 220 min at 50uC and 30 min at 55uC. More importantly,
elevated temperatures augment RNA breakdown; RNA is
thermolabile and susceptible to divalent Mg
2+-catalyzed degrada-
tion [18,21,22]. The RT requires divalent cations, and the
reaction condition of MgCl2 with SuperScript III is 6 mM. It was
reported that the rate of RNA breakdown is directly proportional
to Mg
2+ concentration between 1 and 10 mM at above 37uC, and
Sequencing Complete HIV-1 RNA
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increase above 40uC in the presence of 3 mM Mg
2+ [21,22].
Therefore, although high temperature contributes to resolving
secondary structures of RNA, chances for a full-length mRNA
template are much reduced. For those reasons, reverse transcrip-
tion was carried out at 50uC in our protocol.
A high DNA recombination frequency during long RT-PCR has
been previously reported [23,24]. Recombination frequencies
resulting from the combined procedure of long RT-PCR are
especially higher than long PCR itself or RT-PCR of shorter
molecules [23–26]. For accurate characterization of viral RNA
genomes derived from HIV-1 infected plasma, it is necessary to
minimize artifactual recombination between quasispecies during
RT-PCR. High recombination frequencies are assumed to be
related to the presence of partialcDNA that results from incomplete
cDNA synthesis as well as partial RNA templates caused by
degradation. According to the previous studies [23,24], the
following conditions were recommended in order to decrease
recombination frequencies during long RT-PCR: the minimum
quantity of input HIV-1 RNA, use of mixtures of DNA polymerase
and proofreading enzymes, increased incubation time for cDNA
synthesis, and increased extension time and a minimum number of
cycles for PCR. The last two are associated with achieving complete
strand synthesis to avoid PCR-mediated recombination. A 120 min
RT incubation time and an extension time of 1.5–2 min/kb of
template DNA were suggested as suitable to minimize recombina-
tion in most long RT-PCR [24]. We employed a 120 min RT
incubation time in this protocol after multiple experiments, and
since the excess extension time may compromise yield and
specificity, the optimal PCR extension time was determined based
on template lengths and extension rates of the DNA polymerase.
When the nearly full-length genome sequences were assembled,
the overlapping regions displayed a small number of heteroge-
neous single-base substitutions. Most of them were probably
because heterogeneous quasispecies exist in HIV-1 infected
plasma samples. Any HIV sample contains a population of related
but genetically diverse variants due to the high misincorporation
rate of the HIV-1 RT [8,27,28]. Heterogeneous bases could also
result from mutations created during the in vitro reverse
transcription step; the M-MLV RT is error prone for incorpora-
tion of a wrong nucleotide because of the lack of 39R59
proofreading exonuclease activity [19,29–31]; mutations created
during the reverse transcription are carried on to the final products
to be analyzed, which may interfere with accurate analysis of viral
RNA. The actual empirical error rates of the SuperScript
TM III
RT as used in our assay are unknown. The G to A single-base
substitutions were the most commonly observed among the
heterogeneous bases in the overlapping regions. Recent reports
showed that a cytosine deaminase APOBEC3G (aplolipoprotein B
mRNA-editing enzyme, catalytic polypeptide-like 3G), which is
packaged in HIV-1 virions, induces G to A hypermutation to a
nascent reverse transcript of HIV-1, which contributes in part to
the innate antiviral activity [32–35]. Even though the sequence is
not from an infectious virus, the hypermutated sequences can still
be used for molecular subtyping.
The evidence of dual infections and recombination between
subtypes[36,37] suggest that amplification of fewer fragments is
desirable; while the two-amplicon strategy had an advantage of
increasing the possibility of amplifying the singlespecies of HIV-1, the
three-amplicon strategy was more sensitive for amplification of
samples with low VLs. In a study with SuperScript
TMII MMLV RT,
it was indicated that cDNA synthesis continued to 6-kb and decreased
afterwards [38]. The 59end of an mRNA is generallyrepresented to a
lesser extent than the 39 end in cDNA. This is in accordance with the
increased sensitivity of amplification after cDNA synthesis with
primer, VIF-VPUoutR1, compared to UNINEF 79 in our study. The
limiting dilution method for PCR was used because it is most likely to
pick the predominant strain of the viral population. The relatively
long overlap regions (797- and 321-bp) between the amplicons
increase the likelihood of identifying and constructing full-length
amplicons of the single molecular species.
Previous study has showed a method for the amplification and
sequencing of nearly full-length HIV-1 genomes from RNA[39].
However, their primers were designed based on the sequences in
their South African cohorts and amplify HIV-1 subtype C
preferentially. The primers presented in this paper were designed
to be able to pick up most of the strains from the group M HIV-1
available in the HIV sequence database [2]. Additionally their PCR
productsneedtobeclonedwithacommerciallyavailablecloningkit
in comparison with our protocol with direct-PCR sequencing.
Addition of a cloning step is more time-consuming and can
introduce the possibility of bias. Therefore, the methods described
here provide a more comprehensive protocol of sequencing nearly
full-length HIV-1 RNA compared to currently described methods.
Since this protocol is still not applicable to a low VL range of
HIV-1 infected plasma and serum specimens, further optimization
of the protocol in the future will be necessary. Recent publications
reported a number of reagents that are supposed to facilitate the
disruption of RNA secondary structure and to improve an ability
to achieve full-length cDNA synthesis, including EDTA to
eliminate free Mg
2+, addition of DMSO, RNA chaperone,
formamide and glycerol, and pretreatment of the RNA with
methylmercury hydrozide [18,20,22,40,41]. Recently it has also
been documented that an incorporation of a proofreading function
to RT significantly increased the full-length content of cDNA up to
15-kb [42]. However, the effectiveness of these conditions has
never been tested in controlled experiments harboring defined
structural features capable of blocking RT activity, therefore
supplementary testing will be required before implementing them.
In summary, a new protocol for sequencing nearly full-length
HIV-1 RNA genomes directly form plasma using long RT-PCR
was described in this study. The success of the procedure was
sensitive to VL but was routinely successful for VL greater than
10,000 copies/ml. The method used in this study overcomes some
of the practical difficulties found when trying to sequence nearly
full-genomic HIV-1 from virion RNA. Its importance is two-fold:
first, it confers the ability to sequence the HIV-1 genomes of newly
circulating viruses; second, it can be used to study the molecular
epidemiology of HIV-1 in regions of the world where only serum
or plasma is available.
SUPPORTING INFORMATION
Table S1
Found at: doi:10.1371/journal.pone.0001420.s001 (0.14 MB
DOC)
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